Parkman Healthcare Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-115,777	Closed	-$2.41M	–	89
2023 Q3	$2.41M	Buy	115,777 +15,777	+16%	+$329K	0.44%	66
2023 Q2	$2.4M	Buy	+100,000	New	+$2.4M	0.42%	68